Acadian Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,162	Closed	-$92K	–	2110
2021 Q2	$92K	Buy	4,162 +60	+1%	+$1.27K	﹤0.01%	1651
2021 Q1	$108K	Sell	4,102 -191,484	-98%	-$4.55M	﹤0.01%	1658
2020 Q4	$3.66M	Sell	195,586 -229,930	-54%	-$4.29M	0.01%	589
2020 Q3	$7.22M	Sell	425,516 -160,435	-27%	-$3.12M	0.03%	366
2020 Q2	$13.6M	Sell	585,951 -86,465	-13%	-$1.25M	0.06%	276
2020 Q1	$5.64M	Buy	672,416 +57,882	+9%	+$487K	0.03%	371
2019 Q4	$6M	Buy	614,534 +186,802	+44%	+$1.75M	0.03%	401
2019 Q3	$4.06M	Buy	427,732 +107,423	+34%	+$1.13M	0.02%	509
2019 Q2	$3.8M	Buy	320,309 +230,299	+256%	+$2.77M	0.02%	452
2019 Q1	$1.58M	Buy	90,010 +25,496	+40%	+$424K	0.01%	747
2018 Q4	$1.12M	Buy	+64,514	New	+$1.1M	0.01%	709
2018 Q2	–	Sell	-14,147	Closed	-$201K	–	1893
2018 Q1	$201K	Buy	+14,147	New	+$209K	﹤0.01%	1060
2016 Q4	–	Sell	-116,558	Closed	-$2.25M	–	1809
2016 Q3	$2.25M	Sell	116,558 -459,449	-80%	-$8.99M	0.01%	517
2016 Q2	$11.2M	Sell	576,007 -75,617	-12%	-$1.48M	0.06%	251
2016 Q1	$13.4M	Buy	651,624 +419,622	+181%	+$8.27M	0.07%	240
2015 Q4	$4.76M	Buy	232,002 +195,985	+544%	+$3.76M	0.02%	402
2015 Q3	$616K	Buy	36,017 +5,074	+16%	+$92.7K	﹤0.01%	750
2015 Q2	$576K	Buy	+30,943	New	+$574K	﹤0.01%	771